Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
Frédéric Bert
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
Table 4
Comparison of patients with and without ESBLE infection, by univariate analysis, France, January 2001–April 2010*
| Variable | Patients with ESBLE infection, n = 39 | Patients without ESBLE infection, n = 671 | p value | |
|---|---|---|---|---|
| Preoperative data | ||||
| Mean age, y | 49 | 50 | 0.55 | |
| Male sex | 24 (61.5) | 466 (69.4) | 0.30 | |
| ESBLE fecal carriage | 13 (33.3) | 16 (2.4) | <0.0001 | |
| Viral hepatitis | 13 (33.3) | 248 (37.1) | 0.64 | |
| Hepatocellular carcinoma | 7 (17.9) | 214 (32.3) | 0.061 | |
| Alcoholism | 16 (41) | 219 (32.6) | 0.28 | |
| Acute liver failure | 11 (28.2) | 63 (9.4) | 0.0011 | |
| HIV infection | 1 (2.5) | 20 (3) | 1 | |
| MELD score >25 | 20 (51.3) | 143 (21.4) | <0.0001 | |
| Intensive care stay >48 h† | 14 (35.9) | 80 (11.2) | <0.0001 | |
| Hospital stay >10 d† | 20 (51.3) | 185 (27.6) | 0.0015 | |
| Spontaneous bacterial peritonitis† | 7 (17.9) | 63 (9.4) | 0.082 | |
| Bacteremia† | 5 (12.8) | 70 (10.4) | 0.59 | |
| Intraoperative data | ||||
| Mean duration of surgery, min | 488 | 509 | 0.12 | |
| Mean cold ischemia time, min | 472 | 484 | 0.47 | |
| Kidney transplant | 2 (5.1) | 39 (5.8) | 1 | |
| Living donor | 3 (7.9) | 56 (8.4) | 1 | |
| Mean no. units red blood cells transfused | 5.9 | 4.5 | 0.11 | |
| Roux-en-Y anastomosis | 4 (10.2) | 46 (7.6) | 0.53 | |
| Postoperative data | ||||
| Retransplantation | 3 (7.7) | 40 (6) | 0.72 | |
| Return to surgery | 23 (59) | 228 (34) | 0.0015 | |
| Acute renal failure | 24 (66.7) | 238 (38.1) | 0.0007 | |
*Values are no. (%) except as indicated. ESBLE, extended-spectrum β-lactamase–producing Enterobacteriaceae; MELD, Model for End-stage Liver Disease.
†In the 6 mo before liver transplant.
Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.